These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22835901)

  • 1. Albuminuria, estimated GFR, traditional risk factors, and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular Endstage Disease) study.
    Smink PA; Lambers Heerspink HJ; Gansevoort RT; de Jong PE; Hillege HL; Bakker SJ; de Zeeuw D
    Am J Kidney Dis; 2012 Nov; 60(5):804-11. PubMed ID: 22835901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.
    White SL; Polkinghorne KR; Atkins RC; Chadban SJ
    Am J Kidney Dis; 2010 Apr; 55(4):660-70. PubMed ID: 20138414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR.
    Matsushita K; Tonelli M; Lloyd A; Levey AS; Coresh J; Hemmelgarn BR;
    Am J Kidney Dis; 2012 Aug; 60(2):241-9. PubMed ID: 22560843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
    Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
    Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events and all-cause mortality by albuminuria and decreased glomerular filtration rate in patients with vascular disease.
    Vlek AL; van der Graaf Y; Spiering W; Algra A; Visseren FL;
    J Intern Med; 2008 Oct; 264(4):351-60. PubMed ID: 18522685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should eGFR and albuminuria be added to the Framingham risk score? Chronic kidney disease and cardiovascular disease risk prediction.
    Chang A; Kramer H
    Nephron Clin Pract; 2011; 119(2):c171-7; discussion c177-8. PubMed ID: 21811078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study.
    Hallan S; Astor B; Romundstad S; Aasarød K; Kvenild K; Coresh J
    Arch Intern Med; 2007 Dec; 167(22):2490-6. PubMed ID: 18071172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.
    Astor BC; Hallan SI; Miller ER; Yeung E; Coresh J
    Am J Epidemiol; 2008 May; 167(10):1226-34. PubMed ID: 18385206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of a reduced glomerular filtration rate and interaction with microalbuminuria in resistant hypertension: a cohort study.
    Salles GF; Cardoso CR; Pereira VS; Fiszman R; Muxfeldt ES
    J Hypertens; 2011 Oct; 29(10):2014-23. PubMed ID: 21873887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke.
    Ani C; Ovbiagele B
    J Neurol Sci; 2010 Jan; 288(1-2):123-8. PubMed ID: 19853862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
    Halbesma N; Kuiken DS; Brantsma AH; Bakker SJ; Wetzels JF; De Zeeuw D; De Jong PE; Gansevoort RT
    J Am Soc Nephrol; 2006 Sep; 17(9):2582-90. PubMed ID: 16899519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a general population renal risk score.
    Halbesma N; Jansen DF; Heymans MW; Stolk RP; de Jong PE; Gansevoort RT;
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1731-8. PubMed ID: 21734089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional survey of the prevalence of reduced estimated glomerular filtration rate, albuminuria and cardiovascular risk in a native Spanish population.
    Robles NR; Felix FJ; Fernandez-Berges D; Perez-Castán JF; Zaro MJ; Lozano L; Alvarez-Palacios P; Garcia-Trigo A; Tejero V; Morcillo Y; Hidalgo AB
    J Nephrol; 2013; 26(4):675-82. PubMed ID: 23100180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
    Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
    J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.
    Sasso FC; Chiodini P; Carbonara O; De Nicola L; Conte G; Salvatore T; Nasti R; Marfella R; Gallo C; Signoriello S; Torella R; Minutolo R;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2269-74. PubMed ID: 22090446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.
    Zhang L; Zuo L; Wang F; Wang M; Wang S; Lv J; Liu L; Wang H
    J Am Soc Nephrol; 2006 Sep; 17(9):2617-21. PubMed ID: 16885404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.
    Cheng TY; Wen SF; Astor BC; Tao XG; Samet JM; Wen CP
    Am J Kidney Dis; 2008 Dec; 52(6):1051-60. PubMed ID: 18706747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; DeMicco DA; Fuller JH;
    Am J Kidney Dis; 2009 Nov; 54(5):810-9. PubMed ID: 19540640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
    Clase CM; Gao P; Tobe SW; McQueen MJ; Grosshennig A; Teo KK; Yusuf S; Mann JF;
    Ann Intern Med; 2011 Mar; 154(5):310-8. PubMed ID: 21357908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.